127 related articles for article (PubMed ID: 15531046)
1. Immunogenicity of polyepitope libraries assembled by epitope shuffling: an approach to the development of chimeric gene vaccination against malaria.
Cai QL; Wei F; Lin YH; Shao DD; Wang H
Vaccine; 2004 Nov; 23(2):267-77. PubMed ID: 15531046
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
[TBL] [Abstract][Full Text] [Related]
3. Immunoaffinity purification of polyepitope proteins against Plasmodium falciparum with chicken IgY specific to their C-terminal epitope tag.
Qu JX; Lin YH; Ma RS; Wang H
Protein Expr Purif; 2011 Feb; 75(2):225-9. PubMed ID: 20940054
[TBL] [Abstract][Full Text] [Related]
4. Tandem use of PCR and synthetic peptides to map helper T-cell epitopes on 27-kDa sexual stage antigen of Plasmodium falciparum.
Koski GK; Ploton IN; Viscidi R; Kumar N
Pept Res; 1996; 9(3):127-35. PubMed ID: 8875592
[TBL] [Abstract][Full Text] [Related]
5. A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies.
Theisen M; Soe S; Brunstedt K; Follmann F; Bredmose L; Israelsen H; Madsen SM; Druilhe P
Vaccine; 2004 Mar; 22(9-10):1188-98. PubMed ID: 15003647
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum.
Xu L; Pei X; Berzins K; Chaudhuri A
Exp Parasitol; 2007 Jul; 116(3):214-24. PubMed ID: 17336297
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a recombinant malaria vaccine based on receptor binding domain of Plasmodium falciparum EBA-175.
Pattnaik P; Shakri AR; Singh S; Goel S; Mukherjee P; Chitnis CE
Vaccine; 2007 Jan; 25(5):806-13. PubMed ID: 17045706
[TBL] [Abstract][Full Text] [Related]
9. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.
Patarroyo ME; Amador R; Clavijo P; Moreno A; Guzman F; Romero P; Tascon R; Franco A; Murillo LA; Ponton G
Nature; 1988 Mar; 332(6160):158-61. PubMed ID: 2450281
[TBL] [Abstract][Full Text] [Related]
10. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
Dobaño C; Doolan DL
Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
[TBL] [Abstract][Full Text] [Related]
11. [Construction and expression of Plasmodium berghei chimeric protein in Pichia pastoris and its immunogenicity in mice].
Cao Y; Zhang DM; Pan WQ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Oct; 26(5):327-31. PubMed ID: 19157293
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants.
Wang L; Webster DE; Campbell AE; Dry IB; Wesselingh SL; Coppel RL
Int J Parasitol; 2008 Jan; 38(1):103-10. PubMed ID: 17681344
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites.
Herrington DA; Clyde DF; Losonsky G; Cortesia M; Murphy JR; Davis J; Baqar S; Felix AM; Heimer EP; Gillessen D
Nature; 1987 Jul 16-22; 328(6127):257-9. PubMed ID: 2439920
[TBL] [Abstract][Full Text] [Related]
14. Effects of the configuration of a multi-epitope chimeric malaria DNA vaccine on its antigenicity to mice.
Jiang Y; Lin C; Yin B; He X; Mao Y; Dong M; Xu P; Zhang L; Liu B; Wang H
Chin Med J (Engl); 1999 Aug; 112(8):686-90. PubMed ID: 11601272
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of synthetic peptides derived from Plasmodium falciparum proteins.
Zerpa NC; Wide A; Noda J; Bermúdez H; Pabón R; Noya OO
Exp Parasitol; 2006 Aug; 113(4):227-34. PubMed ID: 16513113
[TBL] [Abstract][Full Text] [Related]
16. Multiple antigen peptides (MAPs) as candidate vaccines against malaria.
Pessi A; Bianchi E; Chiappinelli L; Bonelli F; Tougne C; Lambert PH; Del Giudice G
Parassitologia; 1991 Apr; 33(1):79-84. PubMed ID: 1668679
[TBL] [Abstract][Full Text] [Related]
17. Immunization with hybrid hepatitis B virus core particles carrying circumsporozoite antigen epitopes protects mice against Plasmodium yoelii challenge.
Schödel F; Peterson D; Milich DR; Charoenvit Y; Sadoff J; Wirtz R
Behring Inst Mitt; 1997 Feb; (98):114-9. PubMed ID: 9382731
[TBL] [Abstract][Full Text] [Related]
18. Chimeric epitopes delivered by polymeric synthetic linear peptides induce protective immunity to malaria.
Caro-Aguilar I; Lapp S; Pohl J; Galinski MR; Moreno A
Microbes Infect; 2005 Oct; 7(13):1324-37. PubMed ID: 16253535
[TBL] [Abstract][Full Text] [Related]
19. [Achievements and problems in the development of malaria vaccines].
Martínez-Gómez F
Rev Latinoam Microbiol; 1993; 35(3):319-25. PubMed ID: 8047736
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
